Description
WHOLE BLOOD & BLOOD PRODUCTS - DEOB FUNDS (BP 516C50322)
Base award description: WHOLE BLOOD & BLOOD PRODUCTS
Modification chain · 8 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2025-07-01+$974,000= $974,000
- Mod P000012025-09-16+$89,700= $1,063,700
- Mod P000022025-12-17+$225,000= $1,288,700
- Mod P000032026-02-26-$84,286= $1,204,414
- Mod P000042026-02-27-$1,271= $1,203,143
- Mod P000052026-03-26-$7,965= $1,195,178
- Mod P000062026-06-26-$115,025= $1,080,154
- Mod P000072026-07-07-$18,705= $1,061,449
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2025-07-01 | +$974,000 | $974,000 | WHOLE BLOOD & BLOOD PRODUCTS |
| Mod P00001· FUNDING ONLY ACTION | 2025-09-16 | +$89,700 | $1,063,700 | WHOLE BLOOD & BLOOD PRODUCTS - ADD FUNDS |
| Mod P00002· FUNDING ONLY ACTION | 2025-12-17 | +$225,000 | $1,288,700 | WHOLE BLOOD & BLOOD PRODUCTS - ADD FUNDS |
| Mod P00003· FUNDING ONLY ACTION | 2026-02-26 | −$84,286 | $1,204,414 | WHOLE BLOOD & BLOOD PRODUCTS - DEOB FUNDS (TAMPA 673C50297) |
| Mod P00004· FUNDING ONLY ACTION | 2026-02-27 | −$1,271 | $1,203,143 | WHOLE BLOOD & BLOOD PRODUCTS - DEOB FUNDS (BP 516C50322) |
| Mod P00005· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2026-03-26 | −$7,965 | $1,195,178 | WHOLE BLOOD & BLOOD PRODUCTS - DEOB FUNDS (BP 516C50322) |
| Mod P00006· OTHER ADMINISTRATIVE ACTION | 2026-06-26 | −$115,025 | $1,080,154 | WHOLE BLOOD & BLOOD PRODUCTS - DEOB FUNDS (BP 516C50322) |
| Mod P00007· OTHER ADMINISTRATIVE ACTION | 2026-07-07 | −$18,705 | $1,061,449 | WHOLE BLOOD & BLOOD PRODUCTS - DEOB FUNDS (BP 516C50322) |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI SX3XGHRJMNQ5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24826N0419 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $792,973 | FY2026 |
| 36C24826N0399 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6506 · BLOOD AND BLOOD PRODUCTS | $354,763 | FY2026 |
| 36C24826N0424 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $268,659 | FY2026 |
| 36C24826N0400 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $314,881 | FY2026 |
| 36C24826N0347 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $619,287 | FY2026 |
| 36C24826D0015 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
Other recipients under 6550 from 248-NETWORK CONTRACT OFFICE 8 (36C248) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24826N0554 | AGILENT TECHNOLOGIES INC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $35,634 | FY2026 |
| 36C24826N0393 | SYSMEX AMERICA, INC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $340,032 | FY2026 |
| 36C24826N0602 | GOVERNMENT SCIENTIFIC SOURCE INC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $579,998 | FY2026 |
| 36C24826N0392 | ABBOTT LABORATORIES INC. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $965,388 | FY2026 |
| 36C24826A0019 | GOVERNMENT SCIENTIFIC SOURCE INC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $0 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24825N0836_3600_36C24825D0048_3600 · retrieved 2026-09-26.